Need professional-grade analysis? Visit stockanalysis.com
$1.28B
N/A
N/A
N/A
SanBio Company Limited (SNBIF) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $16.45.
Over the past year, SNBIF has traded between a low of $6.55 and a high of $16.45. The stock has gained 151.1% over this period. It is currently 151.1% above its 52-week low.
SanBio Company Limited has a market capitalization of $1.28B.
SanBio Company Limited engages in the development, production, and sale of regenerative cell medicines for the central nervous system. It develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. The company's research pipeline products also comprise SB623 for chronic cerebral infarction and chronic traumatic cerebral infarction injury, chronic cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, Alzheimer's disease, etc.; SB618 for peripheral neuropathy; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Side-by-side comparison against top Healthcare peers.